Collaboration - May 10, 2021
Glooko collaborates with Eli Lilly
Glooko has announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions. The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen and Tempo Smart Button (currently in late-stage […]
Financing - March 17, 2021
Glooko raises USD 30 million
Glooko has raised a USD 30 million Series D round of funding. The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. The new proceeds will accelerate execution of Glooko’s commercial strategy, including increasing adoption of Glooko’s remote patient monitoring platform, widening […]
Collaboration - January 30, 2017
Novo Nordisk and Glooko partner
Novo Nordisk and Glooko announces that the two companies will work together to deliver jointly-developed and branded digital health solutions for people with diabetes. The non-exclusive collaboration will combine Novo Nordisk’s knowledge of diabetes with Glooko’s digital platform and data analytics expertise. Building on Glooko’s mobile and web platforms, the companies aim to deliver personalised, […]
Agreement - September 13, 2016
Glooko and Diasend merge
Glooko and Diasend have merged into a unified company. Glooko and Diasend offers diabetes management and analytics platforms that facilitate data driven care for patients and clinicians. “This is a big day for us – we are thrilled to come together to be able to deliver products and services that will offer even more value to patients […]
